Cargando…

Establishment and characterization of three stable Basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53

BACKGROUND: Basal/human epidermal growth factor receptor (HER)2-positive (HER2+) breast cancer is resistant to monoclonal antibody (herceptin) treatment. There are currently only three basal/HER2+ breast cancer cell lines available, but they are not from Chinese populations. METHODS: Three immortali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Fei, Zhang, Yanhua, Xu, Xiufang, Luo, Jingfeng, Yang, Fang, Wang, Linbo, Xie, Shuduo, Sun, Jihong, Yang, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098622/ https://www.ncbi.nlm.nih.gov/pubmed/30140169 http://dx.doi.org/10.1186/s12935-018-0617-9

Ejemplares similares

Characteristics of a novel cell line ZJU-0430 established from human gallbladder carcinoma
por: Zhou, Fei, et al.
Publicado: (2019)

Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2/neu receptors of breast carcinoma tissues with derived cell lines
por: Kamalidehghan, Behnam, et al.
Publicado: (2012)

Weight loss reduces basal-like breast cancer through kinome reprogramming
por: Qin, Yuanyuan, et al.
Publicado: (2016)

Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study
por: Yi, Dandan, et al.
Publicado: (2019)

Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient
por: Li, Zhaoqing, et al.
Publicado: (2021)

Establishment and characterization of three new human breast cancer cell lines derived from Chinese breast cancer tissues
por: Shen, Chao, et al.
Publicado: (2009)

Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis
por: Pandrangi, Santhi Latha, et al.
Publicado: (2014)

Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer
por: Gao, Chundi, et al.
Publicado: (2020)

Establishment and characterization of breast cancer organoids from a patient with mammary Paget’s disease
por: Pan, Bo, et al.
Publicado: (2020)

CD4 T-cell immune stimulation of HER2 + breast cancer cells alters response to trastuzumab in vitro
por: Song, Patrick N., et al.
Publicado: (2020)

The development and initial validation of the Health and Reproductive Survey (HeRS)
por: Duffy, Donna, et al.
Publicado: (2021)

The in vitro influences of epidermal growth factor and heregulin-β1 on the efficacy of trastuzumab used in Her-2 positive breast adenocarcinoma
por: Hurrell, Tracey, et al.
Publicado: (2013)

Characterization of ductal carcinoma in situ cell lines established from breast tumor of a Singapore Chinese patient
por: Yong, Jacklyn WY, et al.
Publicado: (2014)

Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies
por: Nasir, Aejaz, et al.
Publicado: (2017)

WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling
por: Jiang, Shaojie, et al.
Publicado: (2019)

Establishment and Characterization of Two Novel Cholangiocarcinoma Cell Lines
por: Zhang, Yanhua, et al.
Publicado: (2019)

Telehealth intervention for Latina breast cancer survivors: A pilot
por: Meneses, Karen, et al.
Publicado: (2018)

Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening
por: Woof, Victoria G, et al.
Publicado: (2021)

Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer
por: Luo, Yanli, et al.
Publicado: (2018)

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
por: Andersen, TI, et al.
Publicado: (2000)

Comparison of characteristics in Mexican women with breast cancer according to healthcare coverage
por: Martinez-Cannon, Bertha Alejandra, et al.
Publicado: (2020)

Health system experiences of breast cancer survivors in urban South Africa
por: Lambert, Madeleine, et al.
Publicado: (2020)

Establishment of primary human breast cancer cell lines using “pulsed hypoxia” method and development of metastatic tumor model in immunodeficient mice
por: Nushtaeva, Anna A., et al.
Publicado: (2019)

KVarPredDB: a database for predicting pathogenicity of missense sequence variants of keratin genes associated with genodermatoses
por: Ying, Yuyi, et al.
Publicado: (2020)

The implications of women’s activity limitations and role disruptions during breast cancer survivorship
por: Keesing, Sharon, et al.
Publicado: (2018)

Establishment and characterization of stable red, far-red (fR) and near infra-red (NIR) transfected canine prostate cancer cell lines
por: Liu, Wen, et al.
Publicado: (2020)

The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells
por: Jiang, Zhinong, et al.
Publicado: (2012)

The relationship between breast size and aspects of health and psychological wellbeing in mature-aged women
por: Spencer, Linda, et al.
Publicado: (2020)

The prognostic values of the expression of Vimentin, TP53, and Podoplanin in patients with cervical cancer
por: Lin, Jiaying, et al.
Publicado: (2017)

Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer
por: Abdeen, Suhaib K., et al.
Publicado: (2018)

“I never heard anything about it”: Knowledge and psychosocial needs of Latina breast cancer survivors with lymphedema
por: Buki, Lydia P, et al.
Publicado: (2021)

A novel Notch1 missense mutation (C1133Y) in the Abruptex domain exhibits enhanced proliferation and invasion in oral squamous cell carcinoma
por: Zheng, Yang, et al.
Publicado: (2018)

Establishment of a doxycycline-regulated cell line with inducible, doubly-stable expression of the wild-type p53 gene from p53-deleted hepatocellular carcinoma cells
por: Chi, Tian-Yi, et al.
Publicado: (2005)

LncRNA TP73‐AS1 promotes nasopharyngeal carcinoma progression through targeting miR-342-3p and M2 polarization via exosomes
por: Yao, Hongchao, et al.
Publicado: (2022)

Study on the correlation between B vitamins and breast cancer
por: Xie, Siqi, et al.
Publicado: (2023)

PTOP and TRF1 help enhance the radio resistance in breast cancer cell
por: Li, Zheng, et al.
Publicado: (2014)

NUCKS overexpression in breast cancer
por: Drosos, Yiannis, et al.
Publicado: (2009)

Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
por: Xu, Feifei, et al.
Publicado: (2014)

Establishment and evaluation of four different types of patient-derived xenograft models
por: Ji, Xiaoqian, et al.
Publicado: (2017)

PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
por: Dou, Xiaoyan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qbd2mhip0271nai8d1vm4s9395